Valthos
Next-generation biodefense
About Valthos
We develop frontier AI systems that identify biological threats and design medical countermeasures in real time. Our founding team comes from Palantir, DeepMind, the Broad Institute, and the Arc Institute.
Pitch deck breakdown
How Valthos would pitch themselves.
Target customer
Business teams looking for modern saas tooling — replacing legacy software or building net-new workflows in this category.
Problem they solve
We develop frontier AI systems that identify biological threats and design medical countermeasures in real time. Our founding team comes from Palantir, DeepMind, the Broad Institute, and the Arc Institute. The category has historically been served by tools that miss the modern workflow this product is built around.
Key differentiator
Valthos differentiates on next-generation biodefense. $0 raised — the company has resources + validation to compound this thesis.
Go-to-market strategy
Early-stage GTM — typically product-led growth (free tier or low-friction onboarding) paired with founder-led sales for the first 100 customers. Heavy content marketing + community presence on Twitter/X, LinkedIn, and category-specific Slack groups.
Valthos website preview
Company facts
- Category
- SaaS
- Funding stage
- Seed
- Total raised
- $0
- Founded
- 2020
- Team size
- 11–50
- HQ
- New York, United States
- Country
- United States
- Website
- valthos.com
Frequently asked questions
What does Valthos do?
We develop frontier AI systems that identify biological threats and design medical countermeasures in real time. Our founding team comes from Palantir, DeepMind, the Broad Institute, and the Arc Institute.
Where is Valthos based?
Valthos is based in New York, United States, United States.
When was Valthos founded?
Valthos was founded in 2020.
How much has Valthos raised?
Valthos has raised $0 in their Seed round.